These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11911209)

  • 1. Application of eudragit RS to thermo-sensitive drug delivery systems. I. Thermo-sensitive drug release from acetaminophen matrix tablets consisting of eudragit RS/PEG 400 blend polymers.
    Fujimori J; Yonemochi E; Fukuoka E; Terada K
    Chem Pharm Bull (Tokyo); 2002 Mar; 50(3):408-12. PubMed ID: 11911209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Eudragit RS to thermo-sensitive drug delivery systems: II. Effect of temperature on drug permeability through membrane consisting of Eudragit RS/PEG 400 blend polymers.
    Fujimori J; Yoshihashi Y; Yonemochi E; Terada K
    J Control Release; 2005 Jan; 102(1):49-57. PubMed ID: 15653133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of plasticizer effect on thermo-responsive properties of Eudragit RS films.
    Khodaverdi E; Tekie FS; Amoli SS; Sadeghi F
    AAPS PharmSciTech; 2012 Sep; 13(3):1024-30. PubMed ID: 22843079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of tablets containing granulations of ibuprofen and an acrylic copolymer prepared by thermal processes.
    Kidokoro M; Shah NH; Malick AW; Infeld MH; McGinity JW
    Pharm Dev Technol; 2001; 6(2):263-75. PubMed ID: 11417001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of theophylline tablets dry powder coated with Eudragit E PO and Eudragit L 100-55.
    Sauer D; McGinity J
    Pharm Dev Technol; 2009; 14(6):632-41. PubMed ID: 19883252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermal treating as a tool to produce plastic pellets based on Eudragit RS PO and RL PO aimed for tableting.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2007 Aug; 67(1):260-7. PubMed ID: 17337169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of film properties to drug release from monolithic films containing adjuvants.
    Jenquin MR; Sarabia RE; Liebowitz SM; McGinity JW
    J Pharm Sci; 1992 Oct; 81(10):983-9. PubMed ID: 1432624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphology and surface properties of blends of Eudragit RS with different poly(ethylene glycol)s.
    Lovrecich M; Rubessa F
    Pharm Dev Technol; 1998 Feb; 3(1):123-9. PubMed ID: 9532607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.
    Alhnan MA; Basit AW
    Eur J Pharm Sci; 2011 Jan; 42(1-2):30-6. PubMed ID: 20950685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of an acrylic polymer blend on the physical stability of film-coated theophylline pellets.
    Kucera S; Shah NH; Malick AW; Infeld MH; McGinity JW
    AAPS PharmSciTech; 2009; 10(3):864-71. PubMed ID: 19568939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of an enteric polymer on drug release rates of theophylline from pellets coated with Eudragit RS 30D.
    Wu C; McGinity JW
    Pharm Dev Technol; 2003; 8(1):103-10. PubMed ID: 12665203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets.
    Grund J; Koerber M; Walther M; Bodmeier R
    Int J Pharm; 2014 Jul; 469(1):94-101. PubMed ID: 24746409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citric acid as a solid-state plasticizer for Eudragit RS PO.
    Schilling SU; Shah NH; Malick AW; Infeld MH; McGinity JW
    J Pharm Pharmacol; 2007 Nov; 59(11):1493-500. PubMed ID: 17976259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermal treating as a tool for sustained release of indomethacin from Eudragit RS and RL matrices.
    Azarmi S; Farid J; Nokhodchi A; Bahari-Saravi SM; Valizadeh H
    Int J Pharm; 2002 Oct; 246(1-2):171-7. PubMed ID: 12270619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained release coating of tablets with Eudragit(®) RS/RL using a novel electrostatic dry powder coating process.
    Qiao M; Luo Y; Zhang L; Ma Y; Stephenson TS; Zhu J
    Int J Pharm; 2010 Oct; 399(1-2):37-43. PubMed ID: 20678560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Eudragit RS-PO and Ethocel 100 matrices for the controlled release of lobenzarit disodium.
    Boza A; Caraballo I; Alvarez-Fuentes J; Rabasco AM
    Drug Dev Ind Pharm; 1999 Feb; 25(2):229-33. PubMed ID: 10065357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel application of Eudragit RL and cholesteryl oleyl carbonate to thermo-sensitive drug delivery system.
    Cetin EO; Gundogdu E; Baspinar Y; Karasulu E; Kirilmaz L
    Drug Dev Ind Pharm; 2013 Dec; 39(12):1881-6. PubMed ID: 22397637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eudragit(®) RS PO/RL PO as rate-controlling matrix-formers via roller compaction: Influence of formulation and process variables on functional attributes of granules and tablets.
    Dave VS; Fahmy RM; Bensley D; Hoag SW
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1240-53. PubMed ID: 22257339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymers with pH-dependent solubility: possibility of use in the formulation of gastroresistant and controlled-release matrix tablets.
    Palmieri GF; Michelini S; Di Martino P; Martelli S
    Drug Dev Ind Pharm; 2000 Aug; 26(8):837-45. PubMed ID: 10900540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.